Merck KGaA (OTCMKTS:MKGAF) Sees Unusually-High Trading Volume – Should You Buy?

Merck KGaA (OTCMKTS:MKGAF) saw unusually-strong trading volume on Tuesday. Approximately 5,085 shares changed hands during trading, an increase of 712% from the previous session’s volume of 626 shares. The stock last traded at $162.30 and had previously closed at $155.45.

Merck KGaA Stock Performance

The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $21.14 billion, a PE ratio of 24.97 and a beta of 0.96. The business has a 50 day simple moving average of $161.19 and a 200 day simple moving average of $151.61.

Institutional Trading of Merck KGaA

A number of hedge funds and other institutional investors have recently made changes to their positions in MKGAF. MASTERINVEST Kapitalanlage GmbH purchased a new position in shares of Merck KGaA during the 2nd quarter valued at about $4,896,000. Puzo Michael J acquired a new stake in Merck KGaA during the second quarter worth about $2,230,000. Somerville Kurt F purchased a new position in Merck KGaA during the second quarter valued at approximately $1,997,000. Pinnacle Holdings LLC purchased a new position in Merck KGaA during the second quarter valued at approximately $1,487,000. Finally, North Star Asset Management Inc. purchased a new stake in Merck KGaA in the 2nd quarter worth approximately $1,411,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

About Merck KGaA

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. Merck KGaA is separate from the U.S.-based Merck & Co, Inc, although the two companies share historical roots.

The company operates through three business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, chemicals and bioprocessing technologies used by pharmaceutical, biotechnology and academic customers.